Moderna Inc
Change company Symbol lookup
Select an option...
MRNA Moderna Inc
MUSA Murphy Usa Inc
SCL Stepan Co
GRWG GrowGeneration Corp
ROG Rogers Corp
ALB Albemarle Corp
DD Dupont De Nemours Inc
SMG Scotts Miracle-Gro Co
MTX Minerals Technologies Inc
HUN Huntsman Corp
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.

Closing Price
$176.40
Day's Change
-0.41 (-0.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
179.14
Day's Low
173.41
Volume
(Light)
Volume:
1,221,141

10-day average volume:
3,746,478
1,221,141

Canada to scrap mask mandate on planes, joining Japan, Hong Kong and U.A.E. in lifting COVID restrictions

8:04 am ET September 28, 2022 (MarketWatch)
Print

By Ciara Linnane

Cases are rising again in northern Europe and almost half of U.S. states

The Canadian government announced Monday it will no longer require people to wear masks on planes to guard against COVID-19, the Associated Press reported

The rules will be lifted Oct. 1. Government officials also confirmed that Canada is dropping the vaccine requirement for people entering the country at the end of the month. The U.S. is not expected to follow suit in the near term.

The news comes at a time when many other places, including Japan and Hong Kong, are lifting travel restrictions. The United Arab Emirates is dropping mask requirements in public places, with the exception of medical facilities, mosques and public transportation, according to a Monday report from the official Emirates News Agency cited by the AP

Dubai's airport, the world's busiest for international travel, was forced to ground all passenger flights when it, along with other U.A.E. airports, closed for eight weeks at the start of the pandemic in 2020. Unlike the capital city of Abu Dhabi, however, Dubai reopened to travelers soon after and did not require proof of vaccination or a negative test to enter most places, which landed it on the "do not travel" lists of the U.K., U.S. and many other countries for much of last year.

In the U.S., known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, where data are not being collected. The daily average for new cases stood at 52,539 on Monday, according to a New York Times tracker, down 23% from two weeks ago.

The tracker shows cases rising in 21 states and in Washington, D.C. The worst-hit state is Montana, where cases are up 75% from two weeks ago, followed by Massachusetts at 40%, New Jersey at 33% and Oregon and Maine at 32%. All of the states in the Northeast are seeing cases rise.

The daily average for hospitalizations was down 15% to 29,443, while the daily average for deaths was up 9% to 417.

From the CDC: Stay Up to Date with COVID-19 Vaccines Including Boosters

Coronavirus Update: MarketWatch's daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

Other COVID-19 news you should know about:

-- Novavax (NVAX) shares rallied Tuesday after the company said that one million doses of its protein-based COVID vaccine Nuvaxovid are now available in the U.K. "With U.K. data showing that people infected with both COVID-19 and the flu are more than five times as likely to die compared to someone with no infection, it is more important than ever to consider any vaccine offered to you by the National Health Service," said Stanley C. Erck, Novavax chief executive, in a statement. The Novavax vaccine uses more conventional technology than the mRNA-based vaccines developed by Pfizer (PFE), BioNTech (BNTX) and Moderna (MRNA), which were first to be approved and used widely in the pandemic.

-- A prominent Chinese commentator said that as the country ponders its COVID-19 policies, epidemiological experts need to speak out, and the government should conduct comprehensive research and make any studies available to the public, Reuters reported. Hu Xijin, former editor-in-chief of the nationalist state tabloid Global Times, made the comments on Chinese social media, garnering 34,000 likes on the microblog Weibo. "About the future, China needs very rational research and calculations," Hu said. The move was unusual, coming after China's leader warned about any comments that criticize the government's COVID policies.

-- A Southern California man was sentenced Monday to four years in federal prison for fraudulently obtaining more than $5 million in COVID-relief loans for three shell companies, the AP reported. Raghavender Reddy Budamala, who was arrested in February while trying to cross the border into Mexico, was also ordered to pay $5.15 million in restitution, the local U.S. Attorney's office said in a statement.

-- COVID cases and hospitalizations are rising in northern Europe as colder weather sets in, Politico reported. The latest data from Belgium, the U.K. and Denmark points to a gradual uptick in the number of cases and hospitalizations. Belgium's health authority said its modeling points to a new COVID wave hitting in mid-October.

Here's what the numbers say:

The global tally of confirmed cases of COVID-19 topped 615.6 million on Monday, while the death toll rose above 6.53 million, according to data aggregated by Johns Hopkins University.

The U.S. leads the world with 96.1 million cases and 1,056,862 fatalities.

The Centers for Disease Control and Prevention's tracker shows that 224.9 million people living in the U.S. are fully vaccinated, equal to 67.8% of the total population. Just 109.6 million have had a booster, equal to 48.7% of the vaccinated population, and 23.1 million of those who are eligible for a second booster have had one, equal to 35.5% of those who received a first booster.

So far, some 4.4 million people have received a booster dose of the new bivalent vaccine that targets the latest omicron subvariants.

-Ciara Linnane

	

(END) Dow Jones Newswires

September 28, 2022 08:04 ET (12:04 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.